Home > Result Summaries: Compounds > Dutasteride > Result Summary for ARI40002

Result Summary for ARI40002

Result Summary
Protocol ID: ARI40002
Clinical Study ID: ARI40002
Official Title: A Pilot, Multi-centre, Double-Blind, Parallel Group, Randomised Study, to Investigate the Effect on Symptoms of Discontinuing Tamsulosin, Following 24 Weeks Combination Treatment with 0.5mg GI198745 (Dutasteride) and 0.4mg Tamsulosin Daily in Subjects with Symptomatic Benign Prostatic Hyperplasi ...
Phase: Phase 3
Study Indications or Diseases:
  • Prostatic Hyperplasia
Generic Name: dutasteride
Trade/Product Name: avodart;avodart
Approved Drug Label: http://www.gsk.com/products/prescription-medicines/index.htm
Results Summary: Click here to download result summary. Click here to download result summary.
Citations:
  • Barkin J, Guimarães M, Jacobi G, et al. Alpha-blocker therapy can be withdrawn in the majority of men following initial combination therapy with the dual 5 alpha-reductase inhibitor dutasteride. Eur Urol 2003; 44: 461–6.